Definium Therapeutics
DFTX----
Definium Therapeutics (DFTX)
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company’s lead product...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Definium Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$59.4737.75%
Forecast & RatingStrong buy
15analysts
- Strong buy73.33%
- Buy26.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 1 day ago, 12:12 AM
Definium Therapeutics (NASDAQ:DFTX) Rating Increased to Hold at Wall Street Zen
- Simplywall · Jul 23 at 12:07 PM
Is Definium Therapeutics (DFTX) Expensive As New GAD Study Sharpens Its Late Stage Case?
- PUBT · Jul 20 at 03:01 PM
Definium Therapeutics issues options for 30,330 shares to new hires under inducement plan
- benzinga_article · Jul 16 at 11:36 AM
Why Is GH Research Stock Trading Higher on Thursday?
- US Stock Market Update · Jul 9 at 03:21 PM
Definium Therapeutics climbs 7% to 52-week high on stock grant news
- US Stock Market Update · Jul 9 at 11:01 AM
Definium Therapeutics climbs 5% to 52-week high after employee stock grant
